Treatment for the Mental Health Impact of Killing in War
The goal of this project is to test the feasibility, acceptability, and efficacy of a treatment module addressing the mental health and functional impact of killing in the war zone.
The investigators will enroll between 12-20 Veterans who have killed in war and have been diagnosed with post-traumatic stress disorder (PTSD) for a pilot study assessing the efficacy of the six-session treatment. Veterans will be randomized either to the treatment or to the waitlist control group.
|Posttraumatic Stress Disorder (PTSD)||Behavioral: Impact of Killing CBT Treatment|
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Treatment for the Mental Health Impact of Killing in War: Augmentation of Existing Evidence-Based Mental Health Interventions|
- Change in psychological symptoms as measured by the Symptom Checklist-90 (SCL-90-R) [ Time Frame: Measured at baseline and study completion (week 7) ]A brief multidimensional self-report inventory that screens for nine symptoms of psychopathology and provides three global distress indicators.
- Change in killing-related maladaptive cognitions as measured by the Killing Cognitions Scale (KCS) [ Time Frame: Measured at baseline and study completion (week 7) ]Assesses killing-related maladaptive cognitions
|Study Start Date:||October 2011|
|Study Completion Date:||June 2013|
|Primary Completion Date:||June 2013 (Final data collection date for primary outcome measure)|
Behavioral: Impact of Killing CBT Treatment
Please refer to this study by its ClinicalTrials.gov identifier: NCT01406834
|United States, California|
|San Francisco VA Medical Center|
|San Francisco, California, United States, 94121|
|Principal Investigator:||Shira Maguen, PhD||University of California San Francisco/ San Francisco VA Medical Center|